Editor in Chief Dr KK Aggarwal, Padma Shri Awardee                                                                               Dated:25 April,2020

Oxford Covid-19 vaccine trial on 510 humans from today

LONDON: The Covid-19 vaccine being developed by the University of Oxford will be tested on hundreds of humans in Britain from Thursday, UK health secretary Matt Hancock announced on Tuesday.
A total of 510 healthy volunteers, aged 18 to 55, will take part in the trial. While some participants will receive the vaccine – called ChAdOx1 nCoV-19 - others will take a control injection for comparison. The trial will continue over a couple of weeks....read more

Indian Govt. brings ordinance making attack on doctors, paramedic staff a non-bailable offence punishable with up to 7 years imprisonment

Doctors, paramedics, and other healthcare professionals are “frontline warriors” in this war against COVID-19. Yet, they have been subject to violence and discrimination. The incidents of violence targeting doctors, nurses, healthcare workers are increasing even as they have been engaged in carrying out their duties....read more

CMAAO Coronavirus Facts and Myth Buster 70

(With regular inputs from Dr Monica Vasudev)
Amendment of Disease Epidemic Act in India
Violence and discrimination against the fraternity has once again come to the fore during the coronavirus pandemic.
Healthcare providers are leading from the front. They must be given the highest form of protection in this critical hour....read more

Debts in Mythology

It is said that there are three debts, which everybody has to pay in his or her lifetime. In Vedic language, they are called Dev Rin, Pitra Rin and Rishi Rin.
In medical language, the body consists of soul, physical body, mind, intellect and ego. The soul is given to us by God or Devtas (Dev Rin), the physical body by our parents (Pitra Rin) and the mind, intellect and ego by our Gurus (Rishi Rin)....read more

Health Sutras By Dr K K Aggarwal

Not using mask when cough and cold



Healthcare News Monitor

No shortage of Hydroxychloroquine in India, reassures IDMA Gujarat Chairman
The New Indian Express- ANI

The Chairman of Indian Drug Manufacturers' Association, Gujarat chapter has asserted that there is no shortage of Hydroxychloroquine in India and the country's current production of HCQ is 35 to 40 crore tablets a month. Viranchi Shah, Chairman, Indian Drug Manufacturers' Association, Gujarat chapter said, "Our current production capacity of Hydroxychloroquine is 35 to 40 crore tablets a month. This is 10 times more than our requirement. There is no shortage of HCQ in India." He continued saying that India holds almost 70 per cent global capacity of manufacturing HCQ. "Before this COVID-19 situation came into the picture, HCQ was traditionally used for treating Malaria and certain arthritis conditions. If we see the last year's consumption, the total consumption of HCQ in India was about 2.4 crore tablets. Compared to that our current production capacity is almost 34-40 cr tablets a month," said Shah. "India is one of the leading manufacturers in pharmaceuticals. We export medicines to almost every country globally. Even during the lockdown with support of the Modi-government, we have been able to maintain the manufacturing and supply of the medicines. We are also in the position to cater to the international demands of medicines," he added.

50-yr-old bacteria drug makes a comeback in fight against coronavirus
Deccan Herald – Kalyan Ray

A medicinally useful microbe discovered by an Indian biologist half-a-century ago has made a comeback in India’s fight against coronavirus as the Council of Scientific and Industrial Research is set to start three clinical trials with a medicine containing an inactivated form of the bacteria. The second trial would on about 500 asymptomatic persons, who may be close contacts of COVID19 patients and health care sta. The objective is to boost their innate immunity and thereby preventing them from acquiring the disease. The third trial will also be on a large number of hospitalised Covid-19 patients who are not critically ill. The aim is to see if the drug can lead to quicker recovery and prevents the disease progression into a more serious one requiring ICU management. “We have received approvals from the Drugs Controller General of India for three trials. The first one will start soon and preliminary results may come in 35-40 days. Depending on the results, we will take a call on the other two trials,” Ram Vishwakarma, director of CSIR-Indian Institute of Integrative Medicine, Jammu and coordinator for the Covid-19 activities at CSIR told DH. At the core of the drug, lies a microbe named Mycobacterium W (MW) that was renamed later as Mycobacterium indicus pranii (MIP) to honour its discoverer Dr Gursaran Pran Talwar – the grand old man of Indian biology – who established the National Institute of Immunology in Delhi. Looking for a vaccine against leprosy, Talwar and his students spotted the MW in the 1970s and extensively studied the germ that was used successfully as a vaccine against leprosy. Because of its several unique properties, other researchers found its utility as a therapy against TB and some form of cancer too several years down the line. The indigenous medicine was developed more than a decade ago in a public-private partnership and the technology was transferred to pharmaceutical major Cadila for commercial manufacturing. The company would now be a part of the trial along with AIIMS, Delhi and Bhopal as well as PGI Chandigarh.

"Most Disturbing": Doctors' Open Letter to Mamata Banerjee On COVID-19
NDTV- Arun Nair

A group of non-resident medical professionals have written an open letter to West Bengal Chief Minister Mamata Banerjee raising concerns over the "gross under-testing" and "misreporting of data" on the cause of death of COVID-19 patients.
Identifying themselves as Bengali physicians, health scientists, and healthcare providers with roots in the state, the healthcare professionsals said that while they have concerns about inadequate testing across India, they find the situation in West Bengal particularly "most disturbing". "In the last week and a half, we have come across or watched with growing concerns, reports on the COVID-19 situation in West Bengal. There are two specific issues that are most disturbing to us: 1) the gross under-testing in West Bengal, and 2) the misreporting of data on the cause of death in COVID-19 patients," the letter said. Citing a report published in news agency Reuters, the doctors said that West Bengal has conducted just 33.7 tests per million as against national average of around 156.9 per million, despite having the capacity to conduct around 1,000 tests a day. "The number of truly affected cases depends on the extent of testing, the accuracy of the test results and, in particular, the frequency and scale of testing of asymptomatic cases who may have been exposed," the letter said. The professionals -- who claimed that they were born, raised, and educated in West Bengal and have families who currently reside in the state -- also said there is evidence over "gross underestimation" of COVID-19 deaths in the state. "The gross underestimation in the number of truly affected cases may have potentially dangerous consequences, specifically in 1) not being prepared with adequate healthcare capacity to handle the pandemic burden in the state, and 2) failing to arrest the spread of the infection by asymptomatic cases who may be spreading unknowingly," it added.

Doctors, Staff At Delhi Hospital LNJP Allegedly Threatened By COVID-19 Patients

Doctors and staff of Lok Nayak Jai Prakash Narain (LNJP) Hospital have alleged that a group of COVID-19 patients who were brought to the hospital through CATS ambulance on Thursday, threatened and manhandled them when the staff asked them to wait for a while.
In a video, hospital staff expressed their plight while narrating the incident. "Today some patients were brought here via CATS ambulance. They were asked to wait for a while as all the doctors here were busy but the patients did not wait and they removed his mask and suit and went very close to the doctor," said a male health care staffer. "When the doctor asked them to maintain social distancing, the patients started arguing and said if they are detected with corona they will infect them (doctors) as well. Later, when the doctor tried to move them away from him, the patients got aggressive and misbehaved with the doctor," he added. He said that even female staffer working with CATS ambulance assaulted the doctor following which the Hospital staff called their female guard. Later, a male staffer of CATS ambulance held our female guard from her neck behind the back, and started abusing her. "We called the guard to control the situation and they even attacked him and abused us. They were repeatedly threatening that if they are detected with corona they will not leave us as well. We are trying to fight against corona but at the same time, we have to fight with these people as well. They misbehaved with us," the health care staffer said.